INR:6539. final ank result Antengene Submits ATG-010 Global Phase 3 Clinical Trial Application to NMPA R&D Daily丨The first to pass the review! Xinhua Pharmaceu ...

Ganesha Gold Nanjing Jianyou and Beijing Taide's "Cisatracurium Besylate Injection" will soon be approved for marketing Novartis CEO's annual salary droppe ...